Alzheimer’s Patients On Antipsychotics Have Nearly Double Death Risk

A new study sponsored by the UK Alzheimer’s Research Trust concluded that antipsychotic drugs commonly prescribed to Alzheimer’s patients in the UK nearly doubles their risk of death over three years. The study was led by Professor Clive Ballard of King’s College London and was published in The Lancet Neurology on 9 January.

More: continued here

Filed under: Alzheimer's / Dementia News XML/RSS Feed on January 11th, 2009